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1. Introduction 
In the course of our studies devoted to human 
serum transferrin, we prepared and purified several 
cyanogen bromide fragments. The present paper deals 
with the establishment of the sequence of two of 
these fragments. 
2. Materials and methods 
Human serum transferrin was obtained from Cohn’s 
fraction IV following the procedure of Roberts et 
al. [ 11. Trypsin (EC 3.4.4.4) and chymotrypsin (EC 
3.4.4.5) were purchased from Worthington. All reagents 
(analytical grade) were obtained from Merck or Pro- 
labo except those employed for the Sequencer which 
were purchased from Socosi (94100 St. Maur, France), 
4sulfophenylisothiocyanate from Pierce and dithio- 
threitol from Calbiochem. Sephadex G-75 (fine) was 
obtained from Pharmacia. 
Preparation of the cyanogen bromide fragments. 
Human serum transferrin was submitted to the.ac- 
tion of cyanogen bromide according to Steers et al. 
[2]. The fragments were purified on Sephadex G-75 
following Jeppson’s procedure [3]. 
Preparation and purification of the tryptic digest 
of peptide CN-C. 20 mg (3.3 PM) of the peptide were 
digested during 22 hr. with 0.66 mg trypsin at 37°C 
in 0.1 M NH4 HC03. Trypsin was pretreated during 
16 hr with 0.0625 M HCl at 37°C. The tryptic 
peptides were obtained by preparative paper electro- 
phoresis (Whatman No. 1) at pH 6.5 (pyridine-water- 
acetic acid, 100: 900: 4, v/v/v) and 50 V/cm and 
when necessary, purified by preparative descending 
paper chromatography (Whatman No. 1; n-butanol- 
pyridine-acetic acid-water, 15: 10:3: 12, v/v/v/v). 
Chymotryptic digestion of peptide CN-C. 6 mg 
(1 PM) of peptide were digested with 0.2 mg chymo- 
trypsin at 37°C in 0.1 M NH, HC03 during 16 hr. 
The purification of the chymotryptic peptides was 
achieved as indicated above for the tryptic peptides. 
The amino acid compositions of the peptides were 
established with a Technicon Autoanalyzer after total 
hydrolysis (6 M HCl; 18 hr; under vacuum). 
Determination of the structure of the peptides. 
Automated Edman degradation was carried out in a 
Socosi Sequencer, Model PS- 100, by the quadrol 
double-cleavage method [4] for peptide CN-C and by 
the dimethylallylamine simple-cleavage method [5] 
for the tryptic split peptides. Dithiothreitol was added 
in l-chlorobutane (30 mgjliter) [6] in order to avoid 
the degradation of thiazolinones. The lysine containing 
peptides were modified with 4sulfophenylisothiocy- 
anate according to Braunitzer et al. [7] ; the N-terminal 
amino acid was identified on an aliquot before modi- 
fication by the dansylation procedure. The thiazolin- 
ones were converted into PTH-amino acids which were 
identified by thin-layer chromatography, gas-liquid 
chromatography and chromatography on an amino 
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Fig. 1. Filtration of a CNBr-human serum transferrin mixture (250 mg) on Sephadex G-75 (130 X 3 cm) in 0.1 M formic acid. 
acid Autoanalyzer after regeneration of the free 
amino acid as previously indicated [8] . 
3. Results 
3.1. Methionine content of human serum transfem’n 
A methionine content of 7.8 residues/mole was 
established by usual analytical techniques with an 
Autoanalyzer. 
3.2. Separation of the cyanogen bromide fragments 
4 fractions (CN-A, CN-B, CN-C and CN-D) were 
obtained by filtration on Sephadex G-75 (fig. 1). 
Similar results were obtained by Jeppson [3] and 
Sutton and Brew [9] with one exception, concern- 
ing fraction CN-D, which was not described by these 
authors. Fraction CN-C was constituted by a single 
chain as only one N-terminal amino acid, Gly, was 
characterized (yield = 9%). Its sequence is described 
below. Fraction CN-D was further purified by paper 
electrophoresis; two methionine-containing peptides 
were characterized, peptide CN-Dl (m = + 0.6 at pH 
6.5; yield 35%; see section 3.3.1) and peptide CN-D2 
(m = 0 at pH 6.5; yield 3%): its structure is under 
investigation. 
3.3. Sequence determinations 
3.3.1. Peptide CN-Dl 
Its amino acid composition was: Asp (1 .OO); Ala 
(l.OO), HSer (0.80), Lys (0.90). The sequence of this 
tetrapeptide was established by classical methods: 
Asn-Ala-Lys-HSer. 
3.3.2. Fragment CN-C 
(a) The N-terminal sequence of peptide CN-C. Auto- 
mated Edman degradation permitted the establishment 
of the N-terminal sequence up to the 32nd amino acid 
(Table 3). 
(b) Study of the tryptic digest of peptide CN-C. 7 
main peptides (Tl-T4; T5a, T5b; T6) were characteriz- 
ed. In table 1, the amino acid compositions, yields, Rf 
and mobility (m) values at pH 6.5 of all the tryptic 
peptides are indicated; these latter account for all the 
amino acids present in peptide CN-C. The structures 
of peptides T2, T3, T4 and T5b were established by 
automated Edman degradation. Peptide T6 as well as 
the two dipeptides Tl and T5a were included in the long 
N-terminal sequence of peptide CN-C. Peptide T6 
contained two lysine residues; the presence of two 
acidic residues prevented the tryptic split after the 
first lysine residue. 
(c) Study of the chymotryptic digest of peptide 
CN-C. 4 main chymotryptic peptides (ClC4) contain- 
ing basic amino acids and thus constituting overlaps 
between tryptic peptides were studied in detail. Table 
2 indicates their R,- and mobility (m) values as well as 
their yields, amino acid compositions and N-terminal 
residues. 
(d) Alignment of the tryptic peptides. Automated 
Edman degradation of peptide CN-C allowed the align- 
ment of tryptic peptides T6 + T5a + Tl + T4; peptide 
C2 is in accordance with this sequence. The chymo- 
tryptic peptides C4, C3 and Cl allowed to join tryptic 
peptides T4 -+ T5b; T5b + T3; T3 -+ T2, respectively. 
The complete structure of peptide CN-C with the 
different overlaps is indicated in Table 3. 
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Table 1 
Amino acid composition of the tryptic peptides of peptide CN-C 
Amino acid T 1 T2 T3 T4 T 5a T5b T6 Total CN-C 
Asp 
Ser 
Glu 
PI0 
GlY 
Ala 
Val 
HSer 
Be 
LeU 
FJhe 
Trp* 
LYS 
His 
Arg 
TOTAL 
yield % 
Rf 
in** 
N-terminal 
ammo acid 
0.92 
(1) 
2.00 
(2) 
1.00 
(1) 
0.70 
(1) 
1.00 
(1) 
0.85 
(1) 
2 5 
35 40 
0.19 0.47 
+ 0.75 + 0.45 
Ser Val 
1.00 
(1) 
1.00 1.55 
(1) (21 
1.45 
(2) 
0.77 
(1) 
1.05 1.07 
(1) (1) 
0.93 
(1) 
1.00 0.89 
(1) (1) 
0.95 1.45 
(1) (2) 
1.06 1.00 
(1) (1) 
0.76 0.78 
(1) (1) 
8 11 
26 37 
0.38 0.45 
+ 0.22 + 0.12 
Asp GlU 
1.00 0.88 
(1) (1) 
1.73 
(2) 
1.00 
(1) 
1.08 1.07 
(1) (1) 
2 5 
30 46 
0.12 0.70 
0 0 
Asp Asp 
2.17 
(2) 
4.32 
(5) 
2.75 
(3) 
1.07 
(1) 
0.85 
(1) 
2.67 
(3) 
1.08 
(1) 
+ 
200 
(2) 
0.72 
(1) 
20 
28 
-0.10 
GlY 
5 
4 
7 
3 
5 
2 
1 
1 
1 
7 
5 
1 
7 
3 
1 
53 
- 
5 
4 
7 
1 
1 
7 
5 
1 
7 
3 
1 
53 
Gly 
Residue number in parentheses, nearest integer based on hydrolysis for 18 hr. 
* Characterized by the Ehrlich reagent. 
** MobilitymatpH6.5;m=+1forArg;m=OforGly;m=-1for~SO,H. 
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Table 2 
Study of 4 main chymotryptic peptides of peptide CN-C, overlaps between 
tryptic split peptides 
Amino acid C 1 c2 c3 c4 
Asp 
Ser 
Glu 
pro 
GlY 
Ala 
Val 
HSer 
Leu 
Phe 
Lys 
His 
Arg 
Total 
Yield % 
0.80 (1) 
0.81 (1) 
0.96 (1) 
(2) 
0.94 (1) 
1.00 
0.95 
(1) 0.95 
(1) 1.45 
(1) 
(2) 
1.52 1.04 
(1) 1.05 
(1) 
(1) 
(1) 1.08 
1.05 
0.68 
0.45 
0.70 
(1) 
(1) 
(1) 
0.80 (1) 
(1) 3.00 (3) 
1.87 (2) 
(1) 0.90 (1) 
(1) 1.00 (1) 
(1) 0.78 (1) 
0.81 
1.00 
0.76 
1.10 
0.80 
7 
47 
0.53 
+ 0.50 
(1) 
8 7 
60 36 
0.12 0.22 
+ 0.27 + 0.17 
10 
14 
0.53 
+ 0.17 
Rf 
m at pH 6.5 
N-terminal 
amino acid Leu GlY LYS Ser 
Residue number in parentheses, nearest integer based on hydrolysis for 18 hr. 
Table 3 
Primary structure of peptide CN-C 
1 Gly-Gly-Lys-Glu-Asp-Leu-Ile-Trp-Glu-Leu-~u-Asn-Gln- 
IIII--71--7?--77--n---n--n--1,----n~ 
W T6 
14 Ala-Gln-Glu-His-Phe-Gly-Lys-Asp-Lys-Ser-Lys-Glu-Phe- 
---n-77--77--n-77n--n--n,/--~- 
T6 m*T5a-- cTl_ cT4- 
c2 * 
27 Gln-Leu-Phe-Ser-Ser-Pro-His-Gly-Lys-Asp-Leu-Leu-Phe- 
-7lNNI/--nN 
T4 _ pT5b- 
c4 
40 Lys-Asp-Ser-Ala-His-Gly-Phe-Leu-Lys-Val-Pro-Pro-Arg-HSer 
T5b 4 T3 - -T2 - ) 
t---c3 - -Cl * 
--n = Amino acid residues determined by automated Edman degradation direct- 
ly on peptide CN-C. 
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4. Conclusion 
The presence of eight methionine residues in human 
serum transferrin was established suggesting the 
presence of 9 cyanogen bromide fragments. Sutton and 
Brew [9] described recently the isolation of 7 frag- 
ments; our results are in accordance with these data 
and complete them as an eighth fragment could be 
sequenced; the last and ninth fragment was also isol- 
ated and its structure is under investigation. 
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